NCT01911975View on ClinicalTrials.gov

Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Small Fiber Neuropathy
Interventions
DRUG

Lacosamide

comparison between lacosamide 200mg twice daily and microcrystalline cellulose (placebo) 200mg twice daily.

DRUG

Placebo

comparison between microcrystalline cellulose (placebo) 200mg twice daily and lacosamide 200mg twice daily.

Trial Locations (1)

Unknown

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Academisch Ziekenhuis Maastricht

OTHER

NCT01911975 - Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy | Biotech Hunter | Biotech Hunter